Literature DB >> 30683268

Endometrial Cancer: Obesity, Genetics, and Targeted Agents.

Megan E McDonald1, David P Bender2.   

Abstract

It is imperative to understand the underlying mechanisms of both endometrial carcinogenesis and recurrence in order to develop more effective prevention and treatment. This article reviews available molecular data, the interplay between endometrial cancer carcinogenesis with obesity and genetics, as well as current targeted therapies.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Endometrial cancer; Genetics; Obesity; Targeted therapeutics

Mesh：

Substances：

Year:  2019        PMID： 30683268     DOI： 10.1016/j.ogc.2018.09.006

Source DB:  PubMed          Journal:  Obstet Gynecol Clin North Am        ISSN： 0889-8545            Impact factor:   2.844


  26 in total

1.  A calcium-dependent phospholipase A2 (cPLA2) expression is regulated by MIG-6 during endometrial tumorigenesis.

Authors:  Hanna E Teasley; Munseok Paul Jeong; Tae Hoon Kim
Journal:  Biochem Biophys Res Commun       Date:  2019-02-14       Impact factor: 3.575

2.  CircRNA circ-ATAD1 is downregulated in endometrial cancer and suppresses cell invasion and migration by downregulating miR-10a through methylation.

Authors:  Pengxia Yang; Kunlun Yun; Ruying Zhang
Journal:  Mamm Genome       Date:  2021-08-18       Impact factor: 2.957

3.  Single cell sequencing analysis and transcriptome analysis constructed the liquid-liquid phase separation(LLPS)-related prognostic model for endometrial cancer.

Authors:  Jiayang Wang; Fei Meng; Fei Mao
Journal:  Front Oncol       Date:  2022-09-14       Impact factor: 5.738

Review 4.  Review of Mendelian Randomization Studies on Endometrial Cancer.

Authors:  Jian-Zeng Guo; Qi-Jun Wu; Fang-Hua Liu; Chang Gao; Ting-Ting Gong; Gang Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-09       Impact factor: 6.055

5.  Long non-coding RNA SOS1-IT1 promotes endometrial cancer progression by regulating hypoxia signaling pathway.

Authors:  Hongyang Liu; Junhu Wan; Quanling Feng; Jingyu Li; Jun Liu; Shihong Cui
Journal:  J Cell Commun Signal       Date:  2021-10-12       Impact factor: 5.908

6.  The oncogenic role of SOX8 in endometrial carcinoma.

Authors:  Wenyan Tian; Zhanghuan Li; Lu Bai; Lingli Chen; Ye Yan; Huihui Li; Yanyan Han; Fei Teng; Chao Gao; Fengxia Xue; Yingmei Wang
Journal:  Cancer Biol Ther       Date:  2020-11-16       Impact factor: 4.742

7.  SPR064, a pro-drug of paclitaxel, has anti-tumorigenic effects in endometrial cancer cell lines and mouse models.

Authors:  Xiaoling Zhao; Weimin Kong; Katherine Tucker; Allison Staley; Yali Fan; Wenchuan Sun; Yajie Yin; Yu Huang; Ziwei Fang; Jiandong Wang; Somdutta Sen; Sundeep Dugar; Chunxiao Zhou; Victoria L Bae-Jump
Journal:  Am J Transl Res       Date:  2020-08-15       Impact factor: 4.060

8.  [Overexpression of leukemia inhibitory factor enhances chemotherapy tolerance of endometrial cancer cells in vitro].

Authors:  Xiaohong Ruan; Meigong Zhong; Wanmin Liu; Qiongru Liu; Wenjie Lu; Yan Zheng; Xin Zhang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2020-01-30

9.  Selection of Endogenous Control Reference Genes for Studies on Type 1 or Type 2 Endometrial Cancer.

Authors:  Thangesweran Ayakannu; Anthony H Taylor; Justin C Konje
Journal:  Sci Rep       Date:  2020-05-21       Impact factor: 4.379

10.  Synchronous quadruple primary malignancies of the cervix, endometrium, ovary, and stomach in a single patient: A case report and review of literature.

Authors:  Dan-Dan Wang; Qing Yang
Journal:  World J Clin Cases       Date:  2019-10-26       Impact factor: 1.337
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.